Abstract
The energy systems of mechanical circulatory support devices have evolved significantly since the inception of the Artificial Heart Program in 1963. The transition from bulky paracorporeal pulsatile blood pumps to continuous flow devices has facilitated the use of mechanical circulatory support (MCS) in a larger population of heart failure patients. While there has been improvement in pump reliability, MCS therapy is still limited by adverse events related to device implantation. The most common events affecting MCS patients are device-related infections. Despite the adoption of smaller continuous flow pump technology, the pump peripherals, including the driveline, have remained the same. Innovative energy transmission techniques, like transcutaneous energy transfer systems (TETS) and wireless power transfer via resonantly coupled inductors, have provided a framework to eliminate device-related infections and prevent hospital readmissions. Five decades after the initial goal of providing fully implantable heart replacement, the advancement of wireless energy systems has provided the basis by which full MCS system implantability and improved patient quality of life can be achieved. This paper reviews the most recent advancements of wireless power transfer specifically for MCS.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28–e292.
Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345(20):1435–43.
Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361(23):2241–51.
Bonde P, Ku NC, Genovese EA, Bermudez CA, Bhama JK, Ciarleglio MM, et al. Model for end-stage liver disease score predicts adverse events related to ventricular assist device therapy. Ann Thorac Surg. 2012;93(5):1541–7; discussion 7–8.
Bonde P, Dew MA, Meyer D, Tallaj JJ, Martin T, Hollifield KA, et al. 4 National trends in readmission (REA) rates following left ventricular assist device (LVAD) therapy. J Heart Lung Transplant. 2011;30(4):S9.
Pereda D, Conte JV. Left ventricular assist device driveline infections. Cardiol Clin. 2011;29(4):515–27.
Kormos RL, Bonde P, Bermudez CA, Lockard KL, Genovese EA, Teuteberg JJ, et al. 261: The ventricular assist device (VAD) driveline: what is the price of living with this technology? J Heart Lung Transplant. 2010;29(2):S89.
Zierer A, Melby SJ, Voeller RK, Guthrie TJ, Ewald GA, Shelton K, et al. Late-onset driveline infections: the Achilles’ heel of prolonged left ventricular assist device support. Ann Thorac Surg. 2007;84(2):515–20.
Waters BH, Sample AP, Bonde P, Smith JR. Powering a ventricular assist device (VAD) with the free-range resonant electrical energy delivery (FREE-D) system. Proc IEEE. 2012;100(1):138–49.
Waters BH, Smith JR, Bonde P. Innovative free-range resonant electrical energy delivery system (FREE-D system) for a ventricular assist device using wireless power. ASAIO J. 2014;60(1):31–7.
Stewart GC, Givertz MM. Mechanical circulatory support for advanced heart failure patients and technology in evolution. Circulation. 2012;125(10):1304–15.
Lubeck DP. The artificial heart. Costs, risks, and benefits--an update. Int J Technol Assess Health Care. 1986;2(3):369–86.
Hogness JR, VanAntwerp M. The artificial heart: prototypes, policies, and patients. Washington, DC: National Academies Press; 1991.
Mott WE, Cole DW Jr. Development of a nuclear-powered artificial heart. ASAIO J. 1972;18(1):152–6.
Norman JC, Molokhia FA, Harmison LT, Whalen RL, Huffman FN. An implantable nuclear-fueled circulatory support system. I. Systems analysis of conception, design, fabrication and initial in vivo testing. Ann Surg. 1972;176(4):492.
Whalen R, Molokhia F, Jeffery D, Huffman F, Norman J. Current studies with simulated nuclear-powered left ventricular assist devices. ASAIO J. 1972;18(1):146–51.
Tchantchaleishvili V, Bush BS, Swartz MF, Day SW, Massey HT. Plutonium-238: an ideal power source for intracorporeal ventricular assist devices? ASAIO J. 2012;58(6):550–3.
Poirier V. Will we see nuclear-powered ventricular assist devices? ASAIO J. 2012;58(6):546–7.
Lillehei CW, Gott VL, Hodges PC, Long DM, Bakken EE. Transistor pacemaker for treatment of complete atrioventricular dissociation. JAMA. 1960;172(18):2006–10.
Chardack WM, Gage AA, Greatbatch W. A transistorized, self-contained, implantable pacemaker for the long-term correction of complete heart block. Surgery. 1960;48(Oct):643–54.
MacLean GK, Aiken PA, Adams WA, Mussivand T. Preliminary evaluation of rechargeable lithium-ion cells for an implantable battery pack. J Power Sources. 1995;56(1):69–74.
MacLean GK, Aiken PA, Adams WA, Mussivand T. Comparison of rechargeable lithium and nickel/cadmium battery cells for implantable circulatory support devices. Artif Organs. 1994;18(4):331–4.
Okamoto E, Watanabe K, Hashiba K, Inoue T, Iwazawa E, Momoi M, et al. Optimum selection of an implantable secondary battery for an artificial heart by examination of the cycle life test. ASAIO J. 2002;48(5):495–502.
Pae WE, Connell JM, Adelowo A, Boehmer JP, Korfer R, El-Banayosy A, et al. Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe. J Heart Lung Transplant. 2007;26(3):219–29.
Schuder JC, Stephenson HE Jr, Townsend JF. Energy transfer into a closed chest by means of stationary coupling coils and a portable high-power oscillator. Trans Am Soc Artif Intern Organs. 1961;7:327–31.
Sherman C, Clay W, Dasse K, Daly B. Energy transmission across intact skin for powering artificial internal organs. Trans Am Soc Artif Intern Organs. 1981;27:137–41.
Puers R, Vandevoorde G. Recent progress on transcutaneous energy transfer for total artificial heart systems. Artif Organs. 2001;25(5):400–5.
Rintoul TC, Dolgin A. Thoratec transcutaneous energy transformer system: a review and update. ASAIO J. 2004;50(4):397–400.
Kusserow BK. The use of a magnetic field to remotely power an implantable blood pump. Preliminary report. Trans Am Soc Artif Intern Organs. 1960;6:292–8.
Schuder JC, Stephenson HE. Energy transport into the closed chest from a set of very-large mutually orthogonal coils. Trans Am Inst Electr Eng Part I: Commun Electron. 1963;81(6):527–34.
Schuder JC. Powering an artificial heart: birth of the inductively coupled-radio frequency system in 1960. Artif Organs. 2002;26(11):909–15.
Mehta SM, Pae WE Jr, Rosenberg G, Snyder AJ, Weiss WJ, Lewis JP, et al. The LionHeart LVD-2000: a completely implanted left ventricular assist device for chronic circulatory support. Ann Thorac Surg. 2001;71(3 Suppl):S156–61; discussion S83–4.
Okamoto E, Yamamoto Y, Akasaka Y, Motomura T, Mitamura Y, Nose Y. A new transcutaneous energy transmission system with hybrid energy coils for driving an implantable biventricular assist device. Artif Organs. 2009;33(8):622–6.
Ozeki T, Chinzei T, Abe Y, Saito I, Isoyama T, Mochizuki S, et al. Functions for detecting malposition of transcutaneous energy transmission coils. ASAIO J. 2003;49(4):469–74.
Iwawaki K, Watada M, Takatani S, Um YS, editors. The design of core-type transcutaneous energy transmission systems for artificial heart. Industrial Electronics Society, 2004 IECON 2004 30th annual conference of IEEE; 2–6 November 2004.
Miura H, Arai S, Kakubari Y, Sato F, Matsuki H, Sato T. Improvement of the transcutaneous energy transmission system utilizing ferrite cored coils for artificial hearts. IEEE Trans Magn. 2006;42(10):3578–80.
Hassler WL, Dlugos DF, inventors; Google Patents, assignee. Low frequency transcutaneous energy transfer to implanted medical device. United States of America patent US 7599743 B2. 2009.
Dowling RD, Gray LA Jr, Etoch SW, Laks H, Marelli D, Samuels L, et al. The AbioCor implantable replacement heart. Ann Thorac Surg. 2003;75(6 Suppl):S93–9.
Dowling RD, Gray LA Jr, Etoch SW, Laks H, Marelli D, Samuels L, et al. Initial experience with the AbioCor implantable replacement heart system. J Thorac Cardiovasc Surg. 2004;127(1):131–41.
Samuels LE, Dowling R. Total artificial heart: destination therapy. Cardiol Clin. 2003;21(1):115–8.
El-Banayosy A, Arusoglu L, Kizner L, Morshuis M, Tenderich G, Pae WE Jr, et al. Preliminary experience with the LionHeart left ventricular assist device in patients with end-stage heart failure. Ann Thorac Surg. 2003;75(5):1469–75.
Mehta SM, Silber D, Boehmer JP, Christensen D, Pae WE Jr. Report of the first U.S. patient successfully supported long term with the LionHeart completely implantable left ventricular assist device system. ASAIO J. 2006;52(6):e31–2.
Yamamoto T, Koshiji K, Homma A, Tatsumi E, Taenaka Y. Improvement in magnetic field immunity of externally-coupled transcutaneous energy transmission system for a totally implantable artificial heart. J Artif Organs. 2008;11(4):238–40.
Fletcher NH, Rossing TD. The physics of musical instruments. 2nd ed. New York: Springer Science & Business Media; 1998. 756 p.
Sample AP, Meyer DA, Smith JR. Analysis, experimental results, and range adaptation of magnetically coupled resonators for wireless power transfer. IEEE Trans Ind Electron. 2011;58(2):544–54.
Tesla N, inventor; Google Patents, assignee. Apparatus for transmitting electrical energy. United States of America patent US1119732 A. 1914.
Kurs A, Karalis A, Moffatt R, Joannopoulos JD, Fisher P, Soljačić M. Wireless power transfer via strongly coupled magnetic resonances. Science. 2007;317(5834):83–6.
Karalis A, Joannopoulos JD, Soljačić M. Efficient wireless non-radiative mid-range energy transfer. Ann Phys. 2008;323(1):34–48.
Cannon BL, Hoburg JF, Stancil DD, Goldstein SC. Magnetic resonant coupling as a potential means for wireless power transfer to multiple small receivers. IEEE Trans Power Electron. 2009;24(7):1819–25.
Waters B, Sample A, Smith J, Bonde P. Toward total implantability using free-range resonant electrical energy delivery system: achieving untethered ventricular assist device operation over large distances. Cardiol Clin. 2011;29(4):609–25.
Waters BH, Park J, Bouwmeester JC, Valdovinos J, Geirsson A, Sample AP, et al. Electrical power to run ventricular assist devices using the free-range resonant electrical energy delivery system. J Heart Lung Transplant. 2018;37(12):1467–74.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Valdovinos, J., Park, J., Smith, J., Bonde, P. (2020). Progress on Wireless LVAD and Energy Sources for Mechanical Circulatory Systems. In: Karimov, J., Fukamachi, K., Starling, R. (eds) Mechanical Support for Heart Failure . Springer, Cham. https://doi.org/10.1007/978-3-030-47809-4_39
Download citation
DOI: https://doi.org/10.1007/978-3-030-47809-4_39
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-47808-7
Online ISBN: 978-3-030-47809-4
eBook Packages: MedicineMedicine (R0)